Adaptive Biotechnologies

Adaptive Biotechnologies

Adaptive Biotechnologies

Founded
2009
Follow us
Alexa global traffic share
Team Size
1–10
Employees
GeekWire

Tech Moves: Accolade’s new board member; Adaptive Biotechnologies names a COO; and more

Forbes Tech

Adaptive Biotechnologies Leverages Microsoft Azure In Search For COVID-19 Answers

GeekWire

Adaptive Biotechnologies posts $26.3M in Q3 revenue, inks partnership with GlaxoSmithKline

GeekWire

Adaptive Biotechnologies will sell 8M shares to accelerate drug development

GeekWire

Adaptive Biotechnologies and Microsoft team up to track coronavirus-fighting cells

FinSMEs

Adaptive Biotechnologies and Microsoft Partner To Decode COVID-19 Immune Response and Provide Open Data Access

the home of AI info

Adaptive Biotechnologies Using Microsoft Azure To Better Detect COVID-19

CNBC Tech , GeekWire

Microsoft and Adaptive Biotechnologies are studying how the human immune system reacts to the coronavirus

GeekWire

Adaptive Biotechnologies plans to sell up to 9.2M shares; revenue grew 52% in 2019

GeekWire

Adaptive Biotechnologies beats estimates with Q3 revenue of $26.1M as shares rise 6%

the home of AI info

Comparing of Adaptive Biotechnologies Corporation (ADPT) and Minerva Neurosciences Inc ...

GeekWire

Universal blood test from Microsoft and Adaptive is a Google-sized data challenge

GeekWire

Adaptive Biotechnologies CEO Chad Robins on the power of mom and being a good listener

GeekWire

Adaptive and Illumina to make immune sequencing kits for labs, streamlining the detection of disease

GeekWire

Adaptive Biotechnologies shares drop as loss widens in first quarterly earnings since IPO

GeekWire

Adaptive Biotechnologies will triple size of its Seattle HQ following IPO

GeekWire

Adaptive Biotechnologies stock soars 90% after ringing Nasdaq opening bell following $300M IPO

GeekWire

Big debut: Shares of Adaptive Biotechnologies rise 100% on first day as public company

Xconomy

Sequencing Firm Adaptive's $300M IPO Comes With Pharma Ambitions

GeekWire

Adaptive Biotechnologies set to go public with valuation above $2B in biggest biotech IPO of 2019